Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels.
J Cancer Res Clin Oncol. 2023 Dec;149(18):16827-16836. doi: 10.1007/s00432-023-05418-2. Epub 2023 Sep 21.
J Cancer Res Clin Oncol. 2023.
PMID: 37733240
SPOCK1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion.
Liu Y, Han T, Wu J, Zhou J, Guo J, Miao R, Xu Z, Xing Y, Bai Y, Hu D.
Liu Y, et al.
J Transl Med. 2023 Dec 12;21(1):909. doi: 10.1186/s12967-023-04616-3.
J Transl Med. 2023.
PMID: 38087364
Free PMC article.
Item in Clipboard
RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness.
Liu Y, Han T, Miao R, Zhou J, Guo J, Xu Z, Xing Y, Bai Y, Wu J, Hu D.
Liu Y, et al.
BMC Cancer. 2024 Jan 2;24(1):7. doi: 10.1186/s12885-023-11761-x.
BMC Cancer. 2024.
PMID: 38167018
Free PMC article.
Item in Clipboard
Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma.
Han T, Liu Y, Zhou J, Guo J, Xing Y, Xie J, Bai Y, Wu J, Hu D.
Han T, et al.
Sci Rep. 2024 Jan 19;14(1):1692. doi: 10.1038/s41598-024-51681-9.
Sci Rep. 2024.
PMID: 38243040
Free PMC article.
Item in Clipboard
Cite
Cite